MEDPLUSPharmacy Retail
Medplus Health Services Ltd — Profit & Loss Statement
₹839.90
-0.78%
Medplus Health Services Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 1.12 Cr | 0.73 Cr | — |
| Tax Rate For Calcs | 0.18 | 0.11 | 0.30 | 0.20 | — |
| Normalized EBITDA | 535.72 Cr | 394.09 Cr | 308.48 Cr | 300.05 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 150.32 Cr | 65.47 Cr | 49.76 Cr | 95.80 Cr | — |
| Reconciled Depreciation | 249.84 Cr | 224.21 Cr | 182.03 Cr | 119.36 Cr | — |
| Reconciled Cost Of Revenue | 4.64K Cr | 4.39K Cr | 3.56K Cr | 2.98K Cr | — |
| EBITDA | 535.72 Cr | 394.09 Cr | 312.23 Cr | 303.73 Cr | — |
| EBIT | 285.88 Cr | 169.88 Cr | 130.19 Cr | 184.37 Cr | — |
| Net Interest Income | -102.59 Cr | -96.43 Cr | -55.24 Cr | -52.70 Cr | — |
| Interest Expense | 102.59 Cr | 96.43 Cr | 83.03 Cr | 66.43 Cr | — |
| Normalized Income | 150.32 Cr | 65.47 Cr | 47.14 Cr | 92.84 Cr | — |
| Net Income From Continuing And Discontinued Operation | 150.32 Cr | 65.47 Cr | 49.76 Cr | 95.80 Cr | — |
| Total Expenses | 5.90K Cr | 5.49K Cr | 4.44K Cr | 3.60K Cr | — |
| Diluted Average Shares | 12.01 Cr | 12.01 Cr | 11.97 Cr | 11.25 Cr | — |
| Basic Average Shares | 11.96 Cr | 11.95 Cr | 11.93 Cr | 11.20 Cr | — |
| Diluted EPS | 12.52 | 5.45 | 4.17 | 8.52 | — |
| Basic EPS | 12.57 | 5.48 | 4.17 | 8.55 | — |
| Diluted NI Availto Com Stockholders | 150.32 Cr | 65.47 Cr | 49.76 Cr | 95.80 Cr | — |
| Net Income Common Stockholders | 150.32 Cr | 65.47 Cr | 49.76 Cr | 95.80 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 150.32 Cr | 65.47 Cr | 49.76 Cr | 95.80 Cr | — |
| Minority Interests | 0.09 Cr | -0.10 Cr | -0.34 Cr | 1.07 Cr | — |
| Net Income Including Noncontrolling Interests | 150.23 Cr | 65.58 Cr | 50.10 Cr | 94.72 Cr | — |
| Net Income Continuous Operations | 150.23 Cr | 65.58 Cr | 50.10 Cr | 94.72 Cr | — |
| Tax Provision | 33.06 Cr | 7.87 Cr | -2.94 Cr | 23.23 Cr | — |
| Pretax Income | 183.29 Cr | 73.44 Cr | 47.16 Cr | 117.94 Cr | — |
| Other Non Operating Income Expenses | 48.62 Cr | 40.01 Cr | 11.23 Cr | 10.35 Cr | — |
| Net Non Operating Interest Income Expense | -102.59 Cr | -96.43 Cr | -55.24 Cr | -52.70 Cr | — |
| Interest Expense Non Operating | 102.59 Cr | 96.43 Cr | 83.03 Cr | 66.43 Cr | — |
| Operating Income | 237.26 Cr | 129.87 Cr | 87.33 Cr | 156.62 Cr | — |
| Operating Expense | 1.26K Cr | 1.10K Cr | 883.66 Cr | 616.38 Cr | — |
| Other Operating Expenses | 282.27 Cr | 253.63 Cr | 93.44 Cr | 65.47 Cr | — |
| Depreciation And Amortization In Income Statement | 249.84 Cr | 224.21 Cr | 181.56 Cr | 119.36 Cr | — |
| Depreciation Income Statement | 249.84 Cr | 224.21 Cr | 179.84 Cr | 118.24 Cr | — |
| Gross Profit | 1.50K Cr | 1.23K Cr | 970.99 Cr | 773.00 Cr | — |
| Cost Of Revenue | 4.64K Cr | 4.39K Cr | 3.56K Cr | 2.98K Cr | — |
| Total Revenue | 6.14K Cr | 5.62K Cr | 4.53K Cr | 3.76K Cr | — |
| Operating Revenue | 6.14K Cr | 5.62K Cr | 4.53K Cr | 3.76K Cr | — |
| Total Unusual Items | — | 3.90 Cr | 3.75 Cr | 3.68 Cr | 2.44 Cr |
| Total Unusual Items Excluding Goodwill | — | 3.90 Cr | 3.75 Cr | 3.68 Cr | 2.44 Cr |
| Interest Income | — | 20.94 Cr | 27.79 Cr | 13.73 Cr | 7.75 Cr |
| Rent Expense Supplemental | — | 0.10 Cr | 0.13 Cr | 0.25 Cr | 0.18 Cr |
| Special Income Charges | — | 3.90 Cr | 3.75 Cr | 3.68 Cr | 2.41 Cr |
| Other Special Charges | — | -4.11 Cr | -3.85 Cr | -3.71 Cr | -2.48 Cr |
| Write Off | — | 0.22 Cr | 0.11 Cr | 0.03 Cr | 0.07 Cr |
| Interest Income Non Operating | — | 20.94 Cr | 27.79 Cr | 13.73 Cr | 7.75 Cr |
| Amortization | — | 1.83 Cr | 1.71 Cr | 1.12 Cr | 0.81 Cr |
| Selling General And Administration | — | 123.41 Cr | 88.71 Cr | 64.23 Cr | 43.44 Cr |
| Selling And Marketing Expense | — | 98.28 Cr | 67.76 Cr | 47.35 Cr | 29.27 Cr |
| General And Administrative Expense | — | 25.13 Cr | 20.95 Cr | 16.88 Cr | 14.16 Cr |
| Rent And Landing Fees | — | 0.10 Cr | 0.13 Cr | 0.25 Cr | 0.18 Cr |
| Impairment Of Capital Assets | — | — | 0.11 Cr | 0.03 Cr | 0.07 Cr |
| Total Other Finance Cost | — | — | — | — | 1.23 Cr |
| Research And Development | — | — | — | — | 0.21 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Medplus Health Services Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.